| ASSET | QUARTER | % RETURN |
|---|---|---|
Eli Lilly and (LLY) | Q1 2018 | -7.71% |
Eli Lilly and (LLY) | Q2 2018 | 11.76% |
Eli Lilly and (LLY) | Q3 2018 | 26.86% |
Eli Lilly and (LLY) | Q4 2018 | 8.02% |
Eli Lilly and (LLY) | Q1 2019 | 13.65% |
Eli Lilly and (LLY) | Q2 2019 | -14.76% |
Eli Lilly and (LLY) | Q3 2019 | 1.03% |
Eli Lilly and (LLY) | Q4 2019 | 18.09% |
Eli Lilly and (LLY) | Q1 2020 | 5.82% |
Eli Lilly and (LLY) | Q2 2020 | 23.1% |
Eli Lilly and (LLY) | Q3 2020 | -9.48% |
Eli Lilly and (LLY) | Q4 2020 | 14.4% |
Eli Lilly and (LLY) | Q1 2021 | 10.99% |
Eli Lilly and (LLY) | Q2 2021 | 23.4% |
Eli Lilly and (LLY) | Q3 2021 | 1% |
Eli Lilly and (LLY) | Q4 2021 | 19.96% |
Eli Lilly and (LLY) | Q1 2022 | 4.79% |
Eli Lilly and (LLY) | Q2 2022 | 13.69% |
Eli Lilly and (LLY) | Q3 2022 | 0.16% |
Eli Lilly and (LLY) | Q4 2022 | 12.52% |
Eli Lilly and (LLY) | Q1 2023 | -5.93% |
Eli Lilly and (LLY) | Q2 2023 | 36.99% |
Eli Lilly and (LLY) | Q3 2023 | 15.45% |
Eli Lilly and (LLY) | Q4 2023 | 8.95% |
Eli Lilly and (LLY) | Q1 2024 | 34.27% |